These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15890686)

  • 1. Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies.
    Safa O; Esmon CT; Esmon NL
    Blood; 2005 Sep; 106(5):1629-35. PubMed ID: 15890686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids.
    Izumi T; Pound ML; Su Z; Iverson GM; Ortel TL
    Thromb Haemost; 2002 Oct; 88(4):620-6. PubMed ID: 12362233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M; Ruggeri L; Barbui T
    Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies.
    Ieko M; Sawada KI; Koike T; Notoya A; Mukai M; Kohno M; Wada N; Itoh T; Yoshioka N
    Semin Thromb Hemost; 1999; 25(5):503-7. PubMed ID: 10625210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro.
    Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
    J Clin Pathol; 1993 Oct; 46(10):908-11. PubMed ID: 8227406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.
    Raschi E; Testoni C; Bosisio D; Borghi MO; Koike T; Mantovani A; Meroni PL
    Blood; 2003 May; 101(9):3495-500. PubMed ID: 12531807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
    Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR
    Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster.
    Jankowski M; Vreys I; Wittevrongel C; Boon D; Vermylen J; Hoylaerts MF; Arnout J
    Blood; 2003 Jan; 101(1):157-62. PubMed ID: 12393462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
    Smirnov MD; Safa O; Regan L; Mather T; Stearns-Kurosawa DJ; Kurosawa S; Rezaie AR; Esmon NL; Esmon CT
    J Biol Chem; 1998 Apr; 273(15):9031-40. PubMed ID: 9535891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
    Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ
    Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
    Blank M; Waisman A; Mozes E; Koike T; Shoenfeld Y
    Int Immunol; 1999 Dec; 11(12):1917-26. PubMed ID: 10590257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
    Intern Med; 1996 Feb; 35(2):105-10. PubMed ID: 8680096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.